Home About us Contact
|
Home About us Contact | ||
|
|
||
Magnetic Suspension (magnetic + suspension)
Selected AbstractsPerformance Characterization of a Rotary Centrifugal Left Ventricular Assist Device With Magnetic SuspensionARTIFICIAL ORGANS, Issue 5 2008Said Jahanmir Abstract:, The MiTiHeart (MiTiHeart Corporation, Gaithersburg, MD, USA) left ventricular assist device (LVAD), a third-generation blood pump, is being developed for destination therapy for adult heart failure patients of small to medium frame that are not being served by present pulsatile devices. The pump design is based on a novel, patented, hybrid passive/active magnetic bearing system with backup hydrodynamic thrust bearing and exhibits low power loss, low vibration, and low hemolysis. Performance of the titanium alloy prototype was evaluated in a series of in vitro tests with blood analogue to map out the performance envelop of the pump. The LVAD prototype was implanted in a calf animal model, and the in vivo pump performance was evaluated. The animal's native heart imparted a strong pulsatility to the flow rate. These tests confirmed the efficacy of the MiTiHeart LVAD design and confirmed that the pulsatility does not adversely affect the pump performance. [source] TC -tuned biocompatible suspension of La0.73Sr0.27MnO3 for magnetic hyperthermiaJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2008N. K. Prasad Abstract La1,xSrxMnO3, a ferromagnet with high magnetization and Curie temperature TC below 70°C, enables its use for magnetic hyperthermia treatment of cancer with a possibility of in vivo temperature control. We found that La0.73Sr0.27MnO3 particles of size range 20,100 nm showed saturation magnetization around 38 emu/g at 20 kOe and a TC value of 45°C. Aqueous suspension of these nanoparticles was prepared using a polymer, acrypol 934, and the biocompatibility of the suspension was examined using HeLa cells. A good heating ability of the magnetic suspension was obtained in the presence of AC magnetic field, and it was found to increase with the amplitude of field. The suspension having concentration of 0.66 mg/mL (e.g., 0.66 mg of nanoparticles with acropyl per milliliter of culture media) was observed to be biocompatible even after 96 h of treatment, as estimated by sulforhodamine B and trypan blue dye exclusion assays. Further, the treatment with the aforementioned concentration did not alter the microtubule cytoskeleton or the nucleus of the cells. However, the bare particles (concentration of 0.66 mg of nanoparticles per milliliter of culture media, but without acropyl) decreased the viability of cell significantly. Our in vitro studies suggest that the suspension (concentration of 0.66 mg/mL) may further be analyzed for in vivo studies. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] Development of a Disposable Maglev Centrifugal Blood Pump Intended for One-Month Support in Bridge-to-Bridge Applications: In Vitro and Initial In Vivo EvaluationARTIFICIAL ORGANS, Issue 9 2009Takeshi Someya Abstract MedTech Dispo, a disposable maglev centrifugal blood pump with two degrees of freedom magnetic suspension and radial magnetic coupling rotation, has been developed for 1-month extracorporeal circulatory support. As the first stage of a two-stage in vivo evaluation, 2-week evaluation of a prototype MedTech Dispo was conducted. In in vitro study, the pump could produce 5 L/min against 800 mm Hg and the normalized index of hemolysis was 0.0054 ± 0.0008 g/100 L. In in vivo study, the pump, with its blood-contacting surface coated with biocompatible 2-methacryloyloxyethyl phosphorylcholine polymer, was implanted in seven calves in left heart bypass. Pump performance was stable with a mean flow of 4.49 ± 0.38 L/min at a mean speed of 2072.1 ± 64.5 rpm. The maglev control revealed its stability in rotor position during normal activity by the calves. During 2 weeks of operation in two calves which survived the intended study period, no thrombus formation was seen inside the pump and levels of plasma free hemoglobin were maintained below 4 mg/dL. Although further experiments are required, the pump demonstrated the potential for sufficient and reliable performance and biocompatibility in meeting the requirements for cardiopulmonary bypass and 1-week circulatory support. [source] Measuring SPIO and Gd contrast agent magnetization using 3,T MRINMR IN BIOMEDICINE, Issue 8 2009Pádraig Cantillon-Murphy Abstract Traditional methods of measuring magnetization in magnetic fluid samples, such as vibrating sample magnetometry (VSM), are typically limited to maximum field strengths of about 1,T. This work demonstrates the ability of MRI to measure the magnetization associated with two commercial MRI contrast agents at 3,T by comparing analytical solutions to experimental imaging results for the field pattern associated with agents in cylindrical vials. The results of the VSM and fitted MRI data match closely. The method represents an improvement over VSM measurements since results are attainable at imaging field strengths. The agents investigated are Feridex, a superparamagnetic iron oxide suspension used primarily for liver imaging, and Magnevist, a paramagnetic, gadolinium-based compound used for tumors, inflammation and vascular lesions. MR imaging of the agents took place in sealed cylindrical vials in the presence of a surrounding volume of deionized water where the effects of the contrast agents had a measurable effect on the water's magnetization in the vicinity of the compartment of contrast agent. A pair of phase images were used to reconstruct a B0 fieldmap. The resultant B0 maps in the water region, corrected for shimming and container edge effects, were used to predict the agent's magnetization at 3,T. The results were compared with the results from VSM measurements up to 1.2,T and close correlation was observed. The technique should be of interest to those seeking quantification of the magnetization associated with magnetic suspensions beyond the traditional scope of VSM. The magnetization needs to be sufficiently strong (Ms , 50 Am2/kg Fe for Feridex and Xm , 5 × 10,5 m3/kg Gd for Magnevist) for a measurable dipole field in the surrounding water. For this reason, the technique is mostly suitable for undiluted agents. Copyright © 2009 John Wiley & Sons, Ltd. [source] Approximation of magnetic behavior of complex nanomagnetic materials, using the "P " curves for structural characterization of magnetic suspensionsPHYSICA STATUS SOLIDI (A) APPLICATIONS AND MATERIALS SCIENCE, Issue 8 2008N. C. Popa Abstract The "P " curves for the structural characterization of magnetic nanoparticles suspensions (complex fluids, complex powders, complex composite materials, or living biological materials having magnetic properties) are the graphical representation of the first derivative (relative to the magnetic field strength H) of the magnetization curve relative to its saturation magnetization. In the case of the above materials, the magnetic properties are conferred to various carrier liquids by artificially integrating in their structure ferromagnetic particles of different sizes. The magnetic properties are usually shown by the hysteresis curve. The structure can be seen by (electronic) micrography. The P curves offer another possibility to determine the structure of the magnetic component of a complex fluid by numerical analysis of the magnetization curve experimentally obtained. Starting from these P curves, the paper presents the possibility to approximate the magnetic behavior of these complex nanomagnetic materials. (© 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) [source] | ||||||||||